Home/Filings/4/0001437749-21-013294
4//SEC Filing

Li Xinzhou 4

Accession 0001437749-21-013294

CIK 0001389545other

Filed

May 24, 8:00 PM ET

Accepted

May 25, 4:46 PM ET

Size

5.0 KB

Accession

0001437749-21-013294

Insider Transaction Report

Form 4
Period: 2021-05-21
Li Xinzhou
10% OwnerOther
Transactions
  • Award

    Restricted Stock Unit

    2021-05-21+30,00030,000 total
    Common stock (30,000 underlying)
Footnotes (1)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant.

Issuer

NovaBay Pharmaceuticals, Inc.

CIK 0001389545

Entity typeother

Related Parties

1
  • filerCIK 0001565534

Filing Metadata

Form type
4
Filed
May 24, 8:00 PM ET
Accepted
May 25, 4:46 PM ET
Size
5.0 KB